Introduction a distance of about 36 kb on mouse chromosome 6 (Gorman et al., 1988) , must be regulated both coordiPeripheral T lymphocytes of the helper or cytotoxic phenately and independently. As an approach toward identinotype express either the CD4 or CD8 coreceptor molefying regulatory elements for the CD8 genes in vivo, cules, respectively, and develop in the thymus from a Hostert et al. (1997a) generated transgenic mice with a common progenitor expressing both coreceptors. Dur-P1 clone containing 80 kb of genomic DNA encoming a process known as positive selection, double-posipassing the entire murine CD8 locus. Proper developtive (DP) thymocytes that express a T cell receptor (TCR) mental stage-and lineage-specific expression of the specific for major histocompatibility complex (MHC) transgenic CD8 reporter was achieved, indicating that all class I develop into CD8 single-positive (SP) thymomajor elements are localized within this large genomic cytes, whereas those specific for MHC class II develop fragment. Similar results were reported for the human into CD4 SP cells. After completing maturation, SP thy-CD8␤ gene in transgenic mice containing a 95 kb genomocytes leave the thymus and constitute the thymusmic fragment surrounding the human CD8␤ locus (Kiefdependent peripheral T cell pool (Kisielow and von fer et al., 1997) . By performing DNase I hypersensitivity Boehmer, 1995; Zuniga-Pflucker and Lenardo, 1996;  (DH) studies on the CD8 locus and testing genomic frag- Marrack and Kappler, 1997) .
ments containing DH sites for enhancer activity, we and The molecular mechanisms that regulate the developothers have recently identified cis-regulatory elements, mental choice between helper and cytotoxic lineage are within a 7.6 kb genomic BamHI fragment, that are innot known (Davis and Littman, 1994; von Boehmer, volved in the regulation of murine CD8 gene expression 1996). Recently, it was shown that transgenic overexin vivo Hostert et al., 1997b) . It pression of an activated form of Notch favors T cell was shown that the E8 I enhancer (initially designated development toward the CD8 lineage, suggesting that E 8SP ) directs expression of a transgenic reporter gene in the Notch pathway might be involved in lineage commitperipheral CD8 ϩ T cells and mature CD8 SP thymocytes ment of DP thymocytes . However, but not at earlier stages of T cell development (e.g., the involvement of known molecular targets of Notch in DP thymocytes). Furthermore, the onset of enhancer thymocyte lineage commitment has not been shown. activity correlated with the final steps of positive selecBecause there is coupling of coreceptor expression and tion, indicating a developmental stage-specific regulation of its activity. In addition, we showed that E8 I , which is located approximately 16 kb upstream of the CD8␣ § To whom correspondence should be addressed (e-mail: ellmeier@ saturn.med.nyu.edu)
gene, directs expression of the reporter gene also in extrathymically derived IEL, thus indicating its specificTo exclude that the expression of CD8 in the absence of E8 I is influenced by the neomycin expression cassette ity toward the CD8␣ gene . However, the identity of enhancer(s) that regulate expression due to transcriptional interference as observed by others (Sleckman et al., 1996) , heterozygous E8 I ϩ/N mice of CD8 in DP thymocytes remained unknown.
In an effort to study E8 I in more detail, we deleted the were crossed with transgenic mice expressing Cre recombinase under the control of the CMV promoter enhancer in embryonic stem (ES) cells by homologous recombination. This experimental approach was de- . Heterozygous E8 I ϩ/⌬ mice (with the deletion of the neomycin gene) were then interbred signed to confirm the proposed role of this enhancer in CD8 SP cells and IEL, and, additionally, to determine if to obtain E8 I ϩ/ϩ, ϩ/⌬, and ⌬/⌬ mice. it could also have a role in the regulation of CD8 expression in DP thymocytes (e.g., by interacting cooperatively Normal T Cell Development in Mice Lacking E8 I with another cis-element that together with E8 I forms a It has been shown that in transgenic mice the 7.6 kb DP-specific enhancer). We show that E8 I is the primary genomic BamHI fragment was sufficient to drive expresenhancer regulating the expression of CD8␣ in the thysion of a reporter gene in mature CD8 SP thymocytes mus-independent subsets of IEL of the gut. IEL from and peripheral CD8 ϩ T cells ; Hostert mice lacking E8 I showed a dramatic decrease of CD8␣␣ et al., 1997b) . This suggested that the enhancer reguhomodimer expression levels (both on TCR␣␤ and lates the expression of CD8 after the final maturation of TCR␥␦ IEL) and the majority of TCR␥␦ IEL lacked exthe CD8 lineage. However, as shown in Figure 2B , the pression of any CD8␣␣ homodimers. In contrast to thyabsence of E8 I had no effect on the expression of CD8 mus-independent T cells, the deletion of E8 I had no (both CD8␣ and CD8␤ expression levels were normal; appreciable effect on CD8 expression in thymus-derived see Table 1 ) and on the appearance of CD8 ϩ T cells in lymphocytes. Neither the appearance of peripheral the periphery. Lymph node or splenic (data not shown) CD8 ϩ T cells nor the development of thymocytes was CD8 ϩ T cells from the knockout mice displayed normal compromised in animals lacking E8 I , indicating that levels of CD8 expression, and the ratio of CD4 ϩ to CD8 ϩ other enhancers are involved in the regulation of CD8 T cells was unchanged (2.6 Ϯ 0.5 and 3.1 Ϯ 0.5 in wildexpression in mature T cells. We identified such additype littermates and E8 I -deficient mice, respectively; tional enhancers, including one specific for DP thymon ϭ 6). In addition, loss of E8 I activity did not interfere cytes, by analyzing reporter gene expression in transwith the development of DP and CD8 SP thymocytes, genic mice. These enhancers directed expression of the indicated by the normal proportion of DP and CD4 or human CD2 (hCD2) reporter at specific stages of T cell CD8 SP thymocytes ( Figure 2A ). Although the expresdevelopment and most likely compensate for E8 I activity sion level of CD8 on peripheral T lymphocytes and DP in E8 I -null mice. However, none of these enhancers dithymocytes was normal, CD8 SP thymocytes (TCR␣␤ hi ) rected expression of the reporter in CD8␣␣ homodimerfrom the knockout animals displayed a 10%-20% deexpressing IEL, thereby explaining the dramatic reduccrease in the level of CD8 expression compared to wildtion of CD8␣ expression in IEL of E8 I Ϫ/Ϫ mice. type littermate controls (Table 1 ). The expression pattern of CD8 in the knockout mice did not differ between animals with or without the deletion of the neomycin Results expression cassette (⌬/⌬ and N/N mice in Figure 2 , respectively). Therefore, the absence of E8 I does not Deletion of the E8 I Enhancer by influence the expression of CD8 in thymus-derived peHomologous Recombination ripheral T cells. This clearly indicates that other cisThe mature and peripheral CD8 ϩ T cell enhancer E8 I regulatory elements (either specific for CD8␣ or CD8␤ Hostert et al., 1997b ) is located or both) compensate for loss of E8 I enhancer activity approximately 16 kb upstream of the CD8␣ gene (Figure and/or are involved in the regulation of CD8 gene ex-1A). To delete the enhancer by homologous recombinapression in mature CD8 SP thymocytes and peripheral tion, we prepared a targeting construct in which the 7.6 CD8 ϩ T cells. kb genomic BamHI fragment containing E8 I (including the two DNase I hypersensitivity sites HS-1 and HS-2) was replaced by a neomycin resistance gene flanked CD8␣␣ Homodimer Expression on Gut Intraepithelial Lymphocytes Is Dramatically Reduced by two loxP sites ( Figure 1B ). Homologous recombination was performed in E14.1 ES cells (Kuhn et al., 1991) in Mice Lacking E8 I Intraepithelial lymphocytes from the gut generally beand several targeted clones were isolated (designated ϩ/N; Figure 1C ). Two ϩ/N ES cell clones were selected long either to the TCR␣␤ or TCR␥␦ T cell lineage. IEL of TCR␣␤ lineage express either CD8␣␤ heterodimers for injection into C57BL/6 blastocysts and chimeric mice obtained from both clones were backcrossed either to or CD8␣␣ homodimers, whereas TCR␥␦-positive IEL express CD8␣␣ homodimers only. It is believed that IEL C57BL/6 or AKR1 mice. The targeted allele was transmitted to the offspring, which were subsequently interbred that express CD8␣␣ homodimers (either of TCR␣␤ or TCR␥␦ lineage) develop extrathymically, whereas the to obtain E8 I ϩ/ϩ, ϩ/N, and N/N mice. There were no significant phenotypic differences between F1 interorigin of CD8␣␤ heterodimer-expressing IEL remains a matter of some controversy (Poussier and Julius, 1994 ; crosses from either of the two ES clones or from the AKR1 and C57BL/6 backcrosses, and therefore we will Rocha et al., 1995; Klein, 1996) . We have shown previously that E8 I directs expression of a transgenic renot distinguish between the clones and between the different strains.
porter gene in intraepithelial lymphocytes. Expression (C) Southern blot of KpnI/XbaI-digested DNA isolated from a wild-type ES cell clone (ϩ/ϩ), from ES cell clones after homologous recombination (ϩ/N), and from an ES cell clone after Cre recombinase-mediated deletion of neomycin (ϩ/⌬). Deletion of the neomycin gene in mice was detected by PCR (PCR-3 fragment) and by Southern blotting with a probe specific for neomycin (data not shown). Only the blot hybridized with the 3Ј probe is shown. The origin of the detected fragments is indicated in (B).
of the hCD2 reporter was observed in all subpopulations N/N or ⌬/⌬) were isolated and analyzed for the expression of CD8␣ on subpopulations expressing either of IEL, including CD8␣␣ ϩ IEL of both the TCR␣␤ and TCR␥␦ lineage . Therefore, IEL from TCR␣␤ or TCR␥␦. In contrast to thymocytes and lymph node T cells, IEL displayed a dramatic reduction in CD8␣ either wild-type or homozygous knockout mice (either 
Numbers indicate n-fold reduction of CD8␣ expression levels on the indicated T cell populations in E8 I knockout mice relative to wild-type littermate controls. To determine the expression levels of CD8␣ on DP or CD8 SP thymocytes, cells were gated on CD4 ϩ TCR␣␤ Ϫ/int or CD4 Ϫ TCR␣␤ hi populations, respectively. For CD8 ϩ LN T cells, relative reduction of expression levels for both CD8␣ and CD8␤ is shown. a Only 25%-50% of TCR␥␦ ϩ IEL in E8 I -deficient mice expressed CD8␣␣ homodimers compared to 80%-90% in wild-type littermate controls.
expression upon deletion of the E8 I enhancer. As shown panel; Table 1 ). These results indicate that E8 I is a major cis-regulatory element for CD8␣ expression in these diin Figure 3A , a 3-to 5-fold reduction in CD8␣ expression levels was observed for TCR␥␦ ϩ cells (Table 1) . Furtherverse IEL populations. more, the percentage of TCR␥␦ ϩ IEL that also expressed CD8␣␣ homodimers was reduced from about 80%-95% in wild-type mice to 20%-50% in N/N and ⌬/⌬ mice Identification of Additional T Cell-Specific Enhancers in the CD8 Locus ( Figure 3A ). Thus, deletion of E8 I resulted in a significant decrease in the level of CD8␣ on TCR␥␦ lineage IEL as
The results from the E8 I enhancer deletion indicated that other cis-regulatory elements are involved in the well as a major reduction in numbers of CD8␣␣ ϩ TCR␥␦ ϩ T cells. A similar, although less dramatic, reduction (1.5-regulation of CD8. However, other enhancers are only able to fully compensate for the mature CD8 ϩ T cellto 3-fold; Table 1 ) of CD8␣ expression was observed on CD8␣␣ ϩ TCR␣␤ ϩ IEL ( Figure 3B , upper panel). CD8␣␤ specific enhancer in thymically derived T cells but not in extrathymically derived CD8␣␣ homodimer-expressing heterodimer-expressing IEL also displayed significantly lower levels of CD8␣ on their surface ( Figure 3B , lower IEL. To identify cis-regulatory elements involved in CD8␣ and/or CD8␤ gene expression, we extended the experienhancer (designated E8 II ) that is active in both immature DP thymocytes and mature CD8 SP thymocytes and T mental approach used to identify E8 I . In brief, a hCD2 reporter gene was cloned downcells. Because TG-23 displayed the same expression patstream of the CD8␣ promoter and genomic fragments containing putative cis-regulatory elements were intern as TG-21, we expected that TG-31 (generated with a 4.1 kb genomic EcoRI/BamHI fragment) would not serted upstream of the CD8␣ promoter and tested for their ability to direct expression of the reporter gene in contain any regulatory activity. Surprisingly, TG-31 directed hCD2 expression only on immature DP thymothymocytes and T cells of transgenic mice. We took advantage of the published hypersensitivity map of the cytes and not on CD4 or CD8 SP thymocytes ( Figure  4A ). To determine the developmental stage at which CD8 locus (Hostert et al., 1997a) and generated a transgenic construct (TG-21) with a 15 kb genomic fraghCD2 expression ceased during the development of CD8 SP thymocytes, TCR␣␤ expression levels were ment containing several DH sites around the 3Ј end of the CD8␤ locus (see Figure 4D ). This and other concompared between hCD2-positive and hCD2-negative cells within the intermediate CD4 lo CD8 ϩ population (Figstructs described below were injected into (B6/D2) F2 mouse eggs to generate transgenic animals. Transgenic ure 6C; see Figure 6A for gating areas). The majority of hCD2-positive CD4 lo CD8 ϩ cells displayed intermediate founders identified by Southern blotting were either analyzed directly or backcrossed to C57BL/6 mice to generlevels of TCR␣␤ (only 21.3% of cells expressed high levels of TCR␣␤), indicating that they were still immaate transgenic lines that were then analyzed.
The expression pattern of the hCD2 reporter in TG-21 ture (Bendelac et al., 1992) . In contrast, hCD2-negative cells showed a higher percentage of cells (44.5%) extransgenic founders or lines reflected the developmental subset-and lineage-specific expression pattern of the pressing high levels of TCR␣␤ ( Figure 6C ). Since expression of hCD2 was variegated in TG-31 (approximately endogenous CD8 gene. During thymocyte development, hCD2 was expressed both in the DP and in the CD8 SP 75% of DP cells expressed hCD2; see Figures 4A and 6A), some hCD2-negative cells within the CD4 lo CD8
ϩ thymocyte population but not in CD4 SP thymocytes ( Figure 4A ). Furthermore, hCD2 expression was obpopulation are of immature phenotype. This might explain why not more than 44.5% of thymocytes within the served on peripheral CD8 ϩ T cells but not on CD4 ϩ cells ( Figure 4B ). No expression of hCD2 was found on B hCD2-negative CD4 lo CD8 ϩ population expressed high levels of TCR␣␤. Consistent with the downregulation of cells (data not shown). We observed position effect variegation of TG-21 expression, as shown previously for hCD2 expression at the TCR int/hi to TCR hi transition during CD8 SP thymocyte development, no hCD2 expression the E8 I enhancer Hostert et al., 1997b) . This is in agreement with the putative absence was observed on lymph node CD8 ϩ T cells ( Figure 4B ). The enhancer activity within this fragment was desigof a locus control region within the CD8 locus (Hostert et al., 1997a) . nated E8 III . During the process of mapping enhancers around the To determine whether this newly identified enhancer directs expression also in CD8␣␣ ϩ cells, IEL from the CD8␤ locus we also analyzed TG-22 and TG-25, which contained additional 3.2 kb of genomic sequence 5Ј to gut mucosa of TG-21 transgenic animals were isolated and analyzed for the expression of hCD2. As shown in the TG-31 fragment (see Figure 5D ). Expression of hCD2 in transgenic mice generated with these constructs was Figure 4C , CD8␣␣ homodimer-expressing IEL (of both TCR␥␦ and TCR␣␤ lineages) did not express hCD2. In observed not only in CD8 ϩ T cells but also in the CD4 ϩ T cell lineage ( Figure 5A ). The percentage of hCD2 ϩ cells contrast, hCD2 was detectable on CD8␣␤ heterodimerexpressing IEL, although the percentage of hCD2 ϩ cells within the CD4 ϩ T cell compartment was always lower than in the CD8 ϩ T cell population in all transgenic foundwithin the CD8␣␤ ϩ IEL was significantly lower than in CD8␣␤ ϩ lymph node T cells (as shown in Figure 4B ), ers and established lines ( Figure 5A ). However, the number of CD4 ϩ T cells expressing hCD2 corresponded proindicating that the enhancer may have only weak activity in CD8␣␤ ϩ IEL. These results therefore indicate that portionally to the percentage of hCD2-expressing CD8 ϩ T cells. Since five hCD2-expressing founders for TG-22 this enhancer functions specifically in T cells expressing CD8␣␤ heterodimers but not CD8␣␣ homodimers.
and three founders for TG-25 (see Table 2 ) displayed this broader expression pattern (directed by an enhancer activity designated E8 IV ), it is unlikely that this is mediIdentification of a Double-Positive ated by position effect variegation due to the site of Thymocyte-Specific Enhancer transgene integration. Expression of hCD2 was also obTo narrow down the region within TG-21 that is involved served in DP thymocytes in TG-22 mice ( Figure 5B ; Table in mediating the expression of hCD2 in CD8␣␤ homodi-2) and in CD8␣␤ heterodimer-expressing IEL but not in mer-expressing cells, transgenic constructs (TG-23 and CD8␣␣ ϩ IEL ( Figure 5C ). TG-31) containing smaller genomic fragments were generated ( Figure 4D ). TG-23, containing a 4.3 kb genomic BamHI fragment, mediated expression of hCD2 in a patSummation of Enhancer Functions during Development tern indistinguishable from TG-21. Expression of hCD2 was observed in DP and CD8 SP thymocytes and in In mice prepared with TG-22, the hCD2 reporter was consistently expressed at higher levels on DP than on peripheral CD8 ϩ T cells (Figures 4A and 4B ). Within the IEL T cell population, hCD2 was detected only on a small CD4 or CD8 SP thymocytes ( Figures 5B and 6A ). This suggests that there is a developmental stage-specific percentage of CD8␣␤ ϩ but not on CD8␣␣ homodimerexpressing cells ( Figure 4C ). Thus, TG-23 contains an change or transition in the activities of the E8 III and/or (B) Lymph node T cells were isolated from the indicated transgenic mice and analyzed by three-color flow cytometry for expression of CD4, CD8, and hCD2. Dot plot shows representative CD4 ϩ and CD8 ϩ T cell gates used for the histograms shown below. (C) Intestinal intraepithelial lymphocytes isolated from transgenic mice TG-21, TG-23, a nontransgenic control mouse, and a transgenic positive control mouse generated with construct TG-8 (containing HS-2 of the E8 I enhancer) were analyzed for expression of CD8␣, CD8␤, and hCD2. Representative gates for CD8␣␣ homodimer-and CD8␣␤ heterodimer-expressing cells are shown in the dot plot. Histograms below show hCD2 expression on gated CD8␣␣ ϩ or CD8␣␤ ϩ IEL. (D) Schematic map of the genomic fragments used for the generation of the transgenic constructs TG-21, TG-23, TG-31, and TG-8. The location of DH sites (indicated by vertical arrowheads) is according to Hostert et al. (1997a) . HS-1 and HS-2 represent the CD8 ϩ T cell linespecific DH sites constituting the E8 I enhancer described earlier . The transcriptional orientation of the CD8␤ gene is indicated by the horizontal arrow. Restriction enzyme sites are BamHI (B), EcoRI (E), and HindIII (H).
E8 IV enhancers. It was previously shown that DP thylevels of hCD2 were examined within these different CD8 ϩ developmental stages. As shown in Figure 6A , a mocytes undergoing positive selection partially downmodulate surface expression of CD8 and CD4. Then, in the progressive decrease to lower levels of hCD2 expression was observed during CD8 lineage development. To presence of MHC class I ligand, they progress through a CD4 lo CD8 ϩ stage toward the mature CD4 Ϫ CD8 ϩ stage examine this further, the developmental stage of thymocytes expressing high or low levels of hCD2 within the in which they display high levels of TCR and low levels of HSA (van Meerwijk and Germain, 1993 analyzing the expression levels of HSA, TCR␣␤, and CD69 et al., 1997) . In contrast, CD4 lo CD8 ϩ cells expressing lower levels of hCD2 displayed the HSA lo TCR␣␤ hi pheno-( Figure 6B ). Thymocytes expressing higher levels of hCD2 were of the immature phenotype (HSA hi   TCR␣␤   int   ) type that characterizes mature cells. These results suggest that the expression of hCD2 in TG-22 mice is govand some of the cells expressed high levels of CD69, indicating that they already received the signal for selection erned by the summation of the activities of E8 III (high expression in DP cells that ceases at the HSA hi TCR␣␤ int/hi (Bendelac et al., 1992; Swat et al., 1993; Merkenschlager 
Summary of hCD2 expression in mice generated with the different transgenic constructs 22, 23, 25, and 31) . The first number next to the transgenic construct indicates how many founders were expressing hCD2 in CD8 ϩ PBLs, while the second number (in brackets) indicates the total numbers of founders obtained. ϩ, ϩ/Ϫ, or Ϫ below the different T lymphocyte populations indicates expression, weak expression, or no expression of hCD2, respectively, on this particular subset in transgenic founders or lines. nd, not determined. a Only three founders generated with TG-21 and two founders from TG-22 or 23 were analyzed for expression of hCD2 on thymocytes or IEL. For TG-31, only thymocytes isolated from two founders were analyzed for hCD2 expression. ϩ CD8 ϩ , CD4 lo CD8 ϩ , and CD4 Ϫ CD8 ϩ populations are shown in the dot plot on the left. Human CD2-high (hi) and hCD2-low (lo) regions in the CD4 lo CD8 ϩ histogram for TG-22#20 indicate representative gates used for further analysis in Figure 6B , while hCD2-negative (neg) and hCD2-positive (pos) regions in the CD4 lo CD8 ϩ histogram for TG-31#9 indicate gates used for further analysis in Figure 6C . (B) Expression of TCR␣␤, CD69, and HSA (left, middle, and right column, respectively) on total CD4 lo CD8 ϩ thymocytes (upper panel) and subsets of this population from TG-22#20 that express either high (middle panel) or low (lower panel) levels of hCD2, as defined in Figure 6A . (C) Expression of TCR␣␤ on total CD4 lo CD8 ϩ thymocytes (upper panel) and subsets of this population from TG-31#9 that are either positive (middle panel) or negative (lower panel) for hCD2 expression, as defined in Figure 6A .
to HSA lo TCR␣␤ hi transition; see also Figure 6C ) and E8 IV lineages. Because expression of the closely linked CD8␣ and CD8␤ genes is likely to be coordinately regulated (lower expression in SP cells) during thymocyte differentiation. Alternatively, it is possible that E8 IV is active in in thymus-dependent T cells, we believe that E8 I represents an enhancer specific for CD8␣ expression in IEL. DP cells as well and that the observed reduction of hCD2 expression during maturation of the CD8 lineage is due Additional T cell-specific enhancers identified near and within the 3Ј end of the CD8␤ gene, designated E8 II , E8 III , to extinguishing E8 III enhancer activity ( Figure 6C ). Additional studies with transgenic constructs containing E8 IV and E8 IV , displayed developmental stage-and lineagespecific activities within the thymic-dependent T cell alone are required to determine if E8 IV is also active in DP thymocytes. compartment but had no activity in the CD8␣␣ ϩ IEL. These novel enhancers are likely to function specifically in thymocyte differentiation and may regulate expresDiscussion sion of CD8␣, CD8␤, or both. The results of this study thus reveal a remarkable diversification in lineage-speIn this study, we have used gene targeting to show that the CD8 enhancer E8 I has a major role in regulating cific regulation of CD8 gene expression by differential utilization of several closely linked cis-elements. CD8␣␣ homodimer expression in IEL. Previous studies had shown that E8 I directs transgenic reporter gene expression both in mature CD8 SP thymocytes and
The Role of E8 I in Thymus-Derived T Cells It has been shown that E8 I is sufficient to direct expres-CD8 ϩ T cells Hostert et al., 1997b) and in extrathymically derived IEL .
sion of a reporter gene in mature CD8 SP thymocytes and in CD8 ϩ T cells, although these studies did not However, targeted deletion of this enhancer had no effect on development of the mature thymus-derived T reveal whether E8 I is the only enhancer regulating expression of CD8 in mature T cells. However, the tight cells, yet resulted in a dramatic reduction in the expression of CD8␣ in CD8␣␣ ϩ IEL of both TCR␣␤ and TCR␥␦ correlation between onset of E8 I activity with the final steps of positive selection indicated a developmental stage-specific regulation of the enhancer and suggested an important role for E8 I in the maturation of CD8 lineage thymocytes Hostert et al., 1997b) . Therefore, it was surprising that the deletion of the enhancer did not affect the expression of CD8 and the appearance of thymus-derived CD8 ϩ T cells in the periphery. This might indicate that the behavior of the enhancer in transgenic mice did not reflect E8 I function in the context of the endogenous chromosomal location. This possibility cannot be ruled out, although we consider this as rather unlikely since a defined developmental stage-specific induction (at the HSA hi TCR int/hi to HSA lo TCR hi transition) of enhancer activity and CD8 subset-specificity of E8 I were observed in at least 19 independent transgenic founders or lines (generated with five different transgenic constructs). Instead, a more favorable explanation would be that additional cis-regu- (Nakayama et al., 1989) . The level of surface CD8.
mature CD8
ϩ T cell enhancer E8 I can be divided into two enhancer subregions designated E8 I -A and E8 I -B (based on the location of the DNase I hypersensitivity sites and on transgenic reporter expression studies; Hostert et al., 1997b) . Klein, 1996) . The expression of CD8␣␣ hond, not determined. modimers on thymus-independent IEL was severely compromised in E8 I -deficient mice, and there was also a modest decrease of CD8␣ levels in CD8␣␤ ϩ IEL. Multiple Subset-Specific Cis-Regulatory Elements TCR␥␦ ϩ IEL displayed reductions in both CD8␣␣ expresin the CD8 Locus sion levels (about 3-to 5-fold) and the percentage of The phenotype observed in E8 I enhancer knockout mice cells expressing CD8␣␣. The reason for loss of CD8␣␣ indicated that there must be other cis-regulatory eleexpression on most, but not all, E8 I -null IEL is not known.
The Role of E8 I in Intestinal IEL
ments that direct CD8 expression not only in immature It is possible that there are sublineages of TCR␥␦ IEL thymocytes but also in peripheral CD8 ϩ T cells. It has that differ in their ability to employ one or more enrecently been shown (Hostert et al., 1997a ) that several hancers other than E8 I for CD8␣ gene expression. Other DH sites are clustered (in a region designated cluster enhancers may thus be able to partially compensate IV) around the CD8␤ gene. Transgenic mice prepared in the CD8␣␣ low TCR␥␦ ϩ sublineage. Future comparative with a construct containing the DH sites from cluster IV studies of the V␥ and V␦ usage by these IEL subsets in (in a 15 kb genomic fragment) directed reporter gene E8 I -knockout mice might help to reveal whether they expression in both immature DP thymocytes and mature represent different sublineages. Alternatively, E8 I may CD8 ϩ T cells. This result is consistent with a recent be involved in establishing an open chromosomal confinding that a 95 kb genomic fragment spanning the figuration of the CD8␣ locus during extrathymic develhuman CD8␤ gene could direct expression of CD8␤ on opment of TCR␥␦ ϩ IEL, and its absence would result in DP thymocytes and mature CD8 SP T cells in transgenic variegated expression of CD8␣.
mice (Kieffer et al., 1997) . TCR␣␤ IEL also displayed lower levels of CD8␣␣ hoIn the process of mapping the cis-acting elements modimers, although to a lower extent (2-to 3-fold). A within the 15 kb genomic fragment, we were able to decrease in the proportion of TCR␣␤ ϩ cells expressing separate an enhancer activity (E8 III ) specific for immature CD8␣␣ homodimers was observed in some E8 I -deficient thymocytes from another enhancer activity (E8 II ) that mice. Nevertheless, the IEL phenotype in E8 I -deficient mediated expression both in DP and in CD8 SP thymomice clearly indicates that E8 I contains major cis-regulacytes (see summary in Figure 7 ). E8 III directed expression tory elements required for CD8␣ expression in this preof the reporter gene in DP thymocytes, but its activity sumptive extrathymically derived lymphocyte popuceased during positive selection as indicated by a gradual loss of hCD2 surface expression on thymocytes at lation. a later developmental stage (i.e., at the TCR␣␤ int/hi to cells and may therefore regulate expression of CD8␣, CD8␤, or both. Studies on the regulation of the murine TCR␣␤ hi transition) and by the absence of hCD2 expression on peripheral T lymphocytes. It remains to be deterHoxB cluster have recently demonstrated that some promoters can either share or compete for the same mined whether there are physically separable DP and SP enhancer activities within E8 II . Further transgenic enhancer (Sharpe et al., 1998) . Analyses on promoter and enhancer interactions in Drosophila have also expression studies will help to clarify this issue.
An additional level of complexity was revealed by the shown that compatibility between the interactions of these cis-regulatory elements, regulated by properties finding that a 3.2 kb genomic region from the CD8␤ locus contains an enhancer activity (E8 IV ) that directs of the promoter region, is one way to achieve selectivity of gene expression in "gene-dense" areas (Li and Noll, expression of the hCD2 reporter not only in CD8 SP thymocytes and CD8 ϩ T cells but also in the CD4 lineage.
1994; Merli et al., 1996; Ohtsuki et al., 1998) .
Since the transgenic constructs in our studies utilized This observation is unlikely to be explained by position effects due to transgene integration, since six indepenthe CD8␣ promoter, it is possible that some enhancers identified in this study (if they are specific for CD8␤) dent founders generated from two different constructs containing the 3.2 kb fragment (in do not function properly in conjunction with the CD8␣ promoter. Incompatibility of enhancer and promoter addition to other genomic regions, see map in Figure 5D ) displayed this expression pattern of the hCD2 reporter combinations could also explain why the E8 I enhancer, which is specific for CD8␣ expression in extrathymically (Table 2) .
It has recently been shown that CD8␤ is expressed derived IEL, does not act upon the CD8␤ gene and its promoter, indicated by the absence of CD8␤ expression at low levels in a subset of CD4 ϩ T cells, which would be consistent with the possibility that E8 IV represents in these T cells. Alternatively, boundary or insulator elements might be localized between the E8 I enhancer and an enhancer specific for expression of CD8␤ in both CD4 ϩ and CD8 ϩ T cells. Expression of a CD8␣ transgene the CD8␤ gene, thereby preventing E8 I and CD8␤ promoter interaction and subsequent expression of CD8␤ in the CD4 subset resulted in the appearance of about 25% mature CD4 ϩ T cells that also expressed CD8␣␤ in IEL. Therefore, in future studies it will be important to generate transgenic constructs in which identified heterodimers, while the majority of the other transgenic CD4 cells expressed only CD8␣␣ homodimers (Hostert enhancers are combined with a reporter gene driven by the CD8␤ promoter. In addition, single or combinatorial et al., 1997a). The enhancer driving CD8␤ expression in the CD4 lineage appears to be weak, since only a subset deletions of the enhancers by homologous recombination should help to determine the specificity of the indiof CD4 ϩ T cells expressed low levels of the CD8␤ protein. This may explain why hCD2 expression was consistently vidual enhancers. The identification of several cis-acting elements from observed in a smaller proportion of CD4 SP cells than in cells of the CD8 lineage, although the possibility remains the CD8 locus provides us now with the opportunity to identify trans-acting factors that bind to these enthat there are additional cis-elements required for expression of CD8␤ in CD4 lineage cells.
hancers. Since CD8 expression correlates with the cytotoxic program of T cells, this could also lead to the identification of factors involved in directing a DP thymoEnhancer Activities and Lineage Commitment cyte into the cytotoxic CD8 lineage. An implication of the finding of the mature CD8 enhancer (E8 I ) was that there must exist other enhancers directing
Experimental Procedures
CD8 expression in immature thymocytes. Therefore, a model was proposed suggesting that different cis-actGeneration of the E8 I Targeting Construct ing elements are involved in regulating CD8 expression A genomic clone containing the enhancer region was isolated from in immature and mature thymocytes and that a switch a 129 genomic library (Stratagene) and subcloned into pBluescript (pBS; Stratagene) . The short and the long arms in enhancer usage and activities occurs during the latest of the targeting construct were isolated as a 1.1 kb BamHI/NotI stages of positive selection and CD8 lineage developfragment (representing one end of the isolated genomic clone) or ment. A prediction of this model is that different sets of as a 5.6 kb AflII (blunted)/BamHI fragment, respectively. The short transcription factors may be involved in regulating CD8 and the long arms were sequentially cloned into a pBS-based vector expression in immature and mature thymocytes, unless containing a polylinker with suitable cloning sites and the thymidine the accessibility of the different enhancers changes durkinase gene driven by the herpes simplex virus enhancer/promoter elements (Thomas and Capecchi, 1990) . A polylinker containing a ing development. The identification of additional CD8 SalI site was then cloned between the short and the long arm of locus enhancers that display developmental stagethe targeting construct and a 1.4 kb XhoI/SalI fragment containing a specific activity supports this model, although some neomycin resistance gene (driven by the thymidine kinase enhancer/ enhancers may be active both in immature and mature promoter) flanked by two loxP sites (Gu et al., 1993) was subsethymocytes.
quently inserted into the SalI site. All cloning steps were performed Our studies have not addressed the specificity of the according to standard procedures (Sambrook et al., 1989) .
E14.1 ES cells (Kuhn et al., 1991) were transfected with 30 g enhancers toward the CD8␣ and/or ␤ genes and the NotI-linearized targeting vector and cultured on mitomycin C-treated close proximity of the four different enhancers raises murine embryonic fibroblasts. Two days after transfection, G418
the question as to how T cell lineage-specificity of CD8␣
(Geneticin, Gibco) was added to a final concentration of 350 g/ml or CD8␤ expression is achieved. In contrast to E8 I , which and after another 2 days gancyclovir (GANC) was added (2 M final directed expression in CD8␣␣ ϩ IEL concentration) for negative selection. There was approximately 10-and hence is likely to function in conjunction with the fold enrichment between plates with and without GANC. Nine days post-transfection, individual ES cell colonies were isolated and half CD8␣ promoter, E8 II , E8 III , and E IV function in CD8␣␤ ϩ of each colony was initially screened in pools of six by PCR analyses transgenic mice, Wojtek Auerbach for providing Cre recombinase transgenic mice, and Steffen Jung and Yong-Rui Zou for comments (PCR product 1 in Figure 1 ). ES cell clones of PCR positive pools were expanded, and correct targeting (both for the 5Ј and 3Ј end) on the manuscript. W. E. was supported by an Erwin-Schrö dinger postdoctoral fellowship from the Fonds zur Fö rderung der wiswas confirmed by Southern blotting. Two targeted ES cell clones were injected into E3.5 C57BL/6 blastocysts and transferred into senschaftlichen Forschung (Vienna, Austria) and is currently an associate of the Howard Hughes Medical Institute. D. R. L. is an investi-(B6/D2) F1 pseudopregnant females. Chimeric mice obtained were then backcrossed to either C57BL/6 or AKR1 mice and transmission gator of the Howard Hughes Medical Institute. of the targeted allele was confirmed by PCR and Southern blot analyses of tail DNA.
Received June 5, 1998; revised August 12, 1998 . To obtain mice that had deleted the neomycin expression cassette, heterozygous enhancer knockout mice were crossed to transgenic mice expressing Cre recombinase under the control of
